Projects
Biotech plant future-proofs antibody drug supply
The global biopharmaceutical company UCB wanted to build a new antibody production facility in Bulle, Switzerland . NNE’s international project team comprised around 70 people from China, Switzerland and Denmark. “ Multi-site execution means that we can provide UCB with a project team that comprises all the necessary capabilities and know-how that a fast-track project of this size requires, ” says project director, Lars Holmgaard Olsen.